Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis

被引:3
|
作者
Peng, Longfei [1 ]
Cao, Zhangjun [1 ]
Wang, Qi [1 ]
Fang, Lu [1 ]
Yan, Songbai [1 ]
Xia, Dian [1 ]
Wang, Jinyou [1 ]
Bi, Liangkuan [1 ]
机构
[1] Anhui Med Univ, Hosp 2, Dept Urol, Hefei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
microarray datasets; differentially expressed genes; Protein-protein interaction network; hub gene; renal cell carcinoma (RCC) clear cell renal cell carcinoma (CCRCC);
D O I
10.3389/fonc.2022.963483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal cell carcinoma (RCC), as one of the most common urological malignancies, has many histologic and molecular subtypes, among which clear cell renal cell carcinoma (ccRCC) is one of the most common causes of tumor-related deaths. However, the molecular mechanism of ccRCC remains unclear. In order to identify the candidate genes that may exist in the occurrence and development of ccRCC, microarray datasets GSE6344, GSE16441, GSE36895, GSE53757 and GSE76351 had been downloaded from Gene Expression Omnibus (GEO) database. Apart from that, the differentially expressed genes (DEGs) were screened through Bioinformatics & Evolutionary Genomics. In addition, the protein-protein interaction network (PPI) was constructed, and the module analysis was performed using STRING and Cytoscape. By virtue of DAVID online database, GO/KEGG enrichment analysis of DEGs was performed. Consequently, a total of 118 DEGs were screened, including 24 up-regulated genes and 94 down-regulated genes. The plug-in MCODE of Cytoscape was adopted to analyze the most significant modules of DEGs. What's more, the genes with degree greater than 10 in DEGs were selected as the hub genes. The overall survival (OS) and disease progression free survival (DFS) of 9 hub genes were analyzed through GEPIA2 online platform. As shown by the survival analysis, SLC34A1, SLC12A3, SLC12A1, PLG, and ENO2 were closely related to the OS of ccRCC, whereas SLC34A1 and LOX were closely related to DFS. Among 11 SLC members, 6 SLC members were highly expressed in non-cancerous tissues (SLC5A2, SLC12A1, SLC12A3, SLC34A1, SLC34A2, SLC34A3). Besides, SLC12A5 and SLC12A7 were highly expressed in ccRCC. Furthermore, SLC12A1-A7, SLC34A1 and SLC34A3 were closely related to OS, whereas SLC12A2/A4/A6/A7 and SLC34A1/A3 were closely related to DFS. In addition, 5 algorithms were used to analyze hub genes, the overlapping genes were AQP2 and KCNJ1. To sum up, hub gene can help us understand the molecular mechanism of the occurrence and development of ccRCC, thereby providing a theoretical basis for the diagnosis and targeted therapy of ccRCC.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Bioinformatic gene analysis for possible biomarkers and therapeutic targets of hypertension-related renal cell carcinoma
    Huang, Wenjie
    Wu, Ke
    Wu, Ruoyu
    Chen, Zhiguo
    Zhai, Wei
    Zheng, Junhua
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2675 - U72
  • [2] Novel biomarkers and therapeutic targets in clear cell renal cell carcinoma (ccRCC)
    Meseguer Navarro, Anna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 17 - 18
  • [3] Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma
    Dong, Yunze
    Zhai, Wei
    Xu, Yunfei
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2555 - 2571
  • [4] GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
    Yao, Lei
    Li, Juanni
    Xu, Zhijie
    Yan, Yuanliang
    Hu, Kuan
    AGING-US, 2022, 14 (06): : 2758 - 2774
  • [5] Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology
    Meng, Zhuo
    Yuan, Bo
    Yang, Shuang
    Fu, Xiaotong
    Zhang, Baoyue
    Xu, Kun
    Bao, Pengfei
    Huang, Youliang
    MEDICINE, 2023, 102 (35) : E34929
  • [6] Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis
    Xu, Yingying
    Kong, Deyang
    Li, Zhongtang
    Qian, Lingling
    Li, Junchao
    Zou, Chunbo
    PLOS ONE, 2021, 16 (08):
  • [7] Screening and identification of key biomarkers in nasopharyngeal carcinoma Evidence from bioinformatic analysis
    Zhang, Ji-Zhou
    Wu, Zeng-Hong
    Cheng, Qing
    MEDICINE, 2019, 98 (48)
  • [8] Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis
    Li, Lin
    Lei, Qingsong
    Zhang, Shujun
    Kong, Lingna
    Qin, Bo
    ONCOLOGY REPORTS, 2017, 38 (05) : 2607 - 2618
  • [9] Biomarkers and new therapeutic targets in renal cell carcinoma
    Di Pietro, G.
    Luu, H. N.
    Spiess, P. E.
    Sexton, W.
    Dickinson, S.
    Parker, A.
    Park, J. Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (18) : 5874 - 5891
  • [10] Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma
    Wang, Ganggang
    Wang, Zheng
    Lu, Haiquan
    Zhao, Zhiqun
    Guo, Liqiang
    Kong, Feng
    Wang, Aizhen
    Zhao, Shengtian
    FRONTIERS IN PHARMACOLOGY, 2022, 13